Why CAR T Therapies Are Hard To Scale, And How Challenges Can Be Solved

3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration
• Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Manufacturing Focus

More from In Vivo